SCHEMBL899181

SCHEMBL899181

Cc1cc(F)ccc1C(O)c1c(C)nc(Cl)n1-c1c(F)cc(F)cc1Cl

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
NR3C2 P08235 1/20 0.31
P2RX7 Q99572 2/20 0.31
CYP3A4 P08684 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL898515 0.94 NR3C2 (0.32) NR3C2P2RX7CYP3A4
SCHEMBL899021 0.94 NR3C2 (0.34) NR3C2P2RX7CYP3A4
SCHEMBL899144 0.86 NR3C2 (0.32) NR3C2
SCHEMBL898917 0.83 NR3C2 (0.31) NR3C2P2RX7CYP3A4
SCHEMBL898935 0.83 NR3C2 (0.36) NR3C2P2RX7
SCHEMBL899352 0.83 NR3C2 (0.33) NR3C2P2RX7CYP3A4
SCHEMBL898064 0.83 MAPK14 (0.33) NR3C2P2RX7
SCHEMBL898920 0.83 NR3C2 (0.37) NR3C2
SCHEMBL899838 0.82 CES2 (0.33) NR3C2
SCHEMBL898785 0.82 NR3C2 (0.33) NR3C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2621907-A1 FUNGICIDAL IMIDAZOLES E.I. Du Pont De Nemours And Company (US) 2013-08-07 EP claimed
US-20130143929-A1 FUNGICIDAL IMIDAZOLES EI DU PONT DE NEMOURS AND COMPANY (US) 2013-06-06 US claimed
WO-2012044650-A1 FUNGICIDAL IMIDAZOLES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2012-04-05 WO claimed
EP-2621907-A1 FUNGICIDAL IMIDAZOLES E.I. Du Pont De Nemours And Company (US) 2013-08-07 EP disclosed
US-20130143929-A1 FUNGICIDAL IMIDAZOLES EI DU PONT DE NEMOURS AND COMPANY (US) 2013-06-06 US disclosed
WO-2012044650-A1 FUNGICIDAL IMIDAZOLES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2012-04-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130143929-A1 FUNGICIDAL IMIDAZOLES CYP1A1, CYP1B1, CYP2E1 NR3C2 2193/4885P2RX7 961/4885CYP3A4 27/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.